Calvo, X., Arenillas, L., Luño, E., Senent, L., Arnan, M., Ramos, F., Pedro, C., Tormo, M., Montoro, J., Díez‐Campelo, M., Blanco, M. L., Arrizabalaga, B., Xicoy, B., Bonanad, S., Jerez, A., Nomdedeu, M., Ferrer, A., Sanz, G. F., & Florensa, L. (n.d.). enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS‐R). American journal of hematology, 92(7), 614–621. http://access.bl.uk/ark:/81055/vdc_100047515862.0x000028